UBS/CALL/YPSOMED N/340.001/0.01/20.09.24 Share Price

Warrant

YPSAIU

CH1315871819

Real-time Bid/Ask 13:51:46 17/06/2024 BST
0.58 CHF / 0.62 CHF -10.45% Intraday chart for UBS/CALL/YPSOMED N/340.001/0.01/20.09.24
Current month+31.37%
1 month+219.05%
Date Price Change
12/06/24 0.67 +15.52%
07/06/24 0.58 +1.75%

Delayed Quote Swiss Exchange

Last update June 12, 2024 at 04:20 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying YPSOMED HOLDING AG
Issuer UBS
YPSAIU
ISINCH1315871819
Date issued 09/01/2024
Strike 340 CHF
Maturity 20/09/2024 (95 Days)
Parity 100 : 1
Emission price 0.12 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.67 CHF
Lowest since issue 0.1 CHF
Delta0.86x
Omega 5.495
Premium1.26x
Gearing6.4x
Moneyness 1.168
Difference Strike -55.25 CHF
Difference Strike %-16.25%
Spread 0.04 CHF
Spread %6.25%
Theoretical value 0.6200
Implied Volatility 30.51 %
Total Loss Probability 17.72 %
Intrinsic value 0.5700
Present value 0.0500
Break even 402.00 CHF
Theta-0.01x
Vega0x
Rho0.01x

Company Profile

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Sector
-
More about the company

Ratings for Ypsomed Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Ypsomed Holding AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
401.5 CHF
Average target price
362 CHF
Spread / Average Target
-9.84%
Consensus
  1. Stock Market
  2. Warrants
  3. YPSAIU Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW